Intended for healthcare professionals

Analysis

Raising the bar for using surrogate endpoints in drug regulation and health technology assessment

BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n2191 (Published 16 September 2021) Cite this as: BMJ 2021;374:n2191

Linked Feature

Should regulatory authorities approve drugs based on surrogate endpoints?